Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 72162-2636

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 72162-2636). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Extended Label (72162 2636 02extendedlabel)

A text panel providing handling instructions for Fosaprepitant injection, lyophilized powder. It states the powder is sterile, for intravenous use only after reconstitution and dilution, and warns against use with solutions containing divalent cations such as calcium or magnesium, including lactated Ringer's and Hartmann's solutions.*

FDA Label Image

Str (Fosaprepitant Structure)

Chemical structure diagram of the active ingredient Fosaprepitant, showing its molecular composition and bonding arrangement.*

FDA Label Image

Label (Lbl721622636)

Label for Fosaprepitant for Injection, 150 mg per vial, lyophilized powder for intravenous injection. Single-dose vial by Bryant Ranch Prepack, relabeled and manufactured by MSN Laboratories Private Limited. The label includes barcodes, storage instructions, inactive ingredients, and directions to scan the package insert QR code for prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.